ESSENTIAL REQUIREMENTS FOR QUALITY CARE: CONCLUSION: Taken together, the information presented in this paper provides a comprehensive description of the essential requirements for establishing a high-quality OG cancer service. The ERQCC expert group is aware that it is not possible to propose a 'one size fits all' system for all countries, but urges that access to multidisciplinary units or centres must be guaranteed for all those with OG cancer.

Solid tumor metastases cause most deaths. Prevention of their occurrence misses suitable anti-metastases medication. Migrastatics is the answer based on the link between the in vivo metastatic activity and the in vitro enhanced migration of cancer cells. Therefore, we decided to develop a rapid test for qualifying the expected migrastatic potential of some medicines suitable for repurposing. The chosen holographic microscope Q-PHASE provides reliable multifield time-lapse recording and simultaneous analysis of the cell morphology, migration, and growth. The results of the methodology of primary assessment of the migrastatic potential exerted by the selected medicines on preferred cancer cell lines are presented.

Solid tumor metastases cause most deaths. Prevention of their occurrence misses suitable anti-metastases medication. Migrastatics is the answer based on the link between the in vivo metastatic activity and the in vitro enhanced migration of cancer cells. Therefore, we decided to develop a rapid test for qualifying the expected migrastatic potential of some medicines suitable for repurposing. The chosen holographic microscope Q-PHASE provides reliable multifield time-lapse recording and simultaneous analysis of the cell morphology, migration, and growth. The results of the methodology of primary assessment of the migrastatic potential exerted by the selected medicines on preferred cancer cell lines are presented.

Solid tumor metastases cause most cancer-related deaths. The prevention of their occurrence misses suitable anti-metastases medicines newly labeled as migrastatics. The first indication of migrastatics potential is based on an inhibition of in vitro enhanced migration of tumor cell lines. Therefore, we decided to develop a rapid test for qualifying the expected migrastatic potential of some drugs for repurposing. The chosen Q-PHASE holographic microscope provides reliable multifield time-lapse recording and simultaneous analysis of the cell morphology, migration, and growth. The results of the pilot assessment of the migrastatic potential exerted by the chosen medicines on selected cell lines are presented.